INR 44.04
(1.17%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 579.88 Million INR | -37.24% |
2022 | 1.11 Billion INR | 80.82% |
2021 | 617 Million INR | 79.83% |
2020 | 343.1 Million INR | 33.6% |
2019 | 256.81 Million INR | 22.98% |
2018 | 208.82 Million INR | -32.01% |
2017 | 307.15 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 192.04 Million INR | 2.75% |
2023 FY | 700.15 Million INR | -37.24% |
2023 Q4 | 186.9 Million INR | -47.22% |
2023 Q1 | 302.94 Million INR | -0.58% |
2023 Q2 | 344.61 Million INR | 13.76% |
2023 Q3 | 354.12 Million INR | 2.76% |
2022 Q1 | 260.26 Million INR | 655.55% |
2022 Q4 | 304.7 Million INR | 14.45% |
2022 Q3 | 266.23 Million INR | -6.42% |
2022 Q2 | 284.49 Million INR | 9.31% |
2022 FY | 1.11 Billion INR | 80.82% |
2021 Q3 | 232.34 Million INR | 18.28% |
2021 Q4 | 34.44 Million INR | -85.17% |
2021 Q2 | 196.43 Million INR | 87.63% |
2021 Q1 | 104.69 Million INR | 327.6% |
2021 FY | 617 Million INR | 79.83% |
2020 FY | 343.1 Million INR | 33.6% |
2020 Q3 | 149.16 Million INR | 25.09% |
2020 Q2 | 119.24 Million INR | 95.11% |
2020 Q1 | 61.11 Million INR | 0.0% |
2020 Q4 | -45.99 Million INR | -130.84% |
2019 FY | 256.81 Million INR | 22.98% |
2018 FY | 208.82 Million INR | -32.01% |
2017 FY | 307.15 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Bajaj HealthCare Limited | 985.34 Million INR | 41.149% |
Hikal Limited | 4.46 Billion INR | 87.009% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -40.604% |
Morepen Laboratories Limited | 1.98 Billion INR | 70.823% |
Themis Medicare Limited | 1.12 Billion INR | 48.491% |
Aarti Drugs Limited | 1.16 Billion INR | 50.33% |
Albert David Limited | 1.02 Billion INR | 43.489% |
Alembic Limited | 872.45 Million INR | 33.534% |
Alkem Laboratories Limited | 32.83 Billion INR | 98.234% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 96.346% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -27.284% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -8402.742% |
FDC Limited | 3.49 Billion INR | 83.431% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 95.018% |
Gufic Biosciences Limited | 1.18 Billion INR | 51.13% |
Hester Biosciences Limited | 908.84 Million INR | 36.195% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 72.701% |
Ind-Swift Limited | 946.56 Million INR | 38.738% |
Innova Captab Limited | 931.03 Million INR | 37.716% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 73.653% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -32.228% |
Jubilant Pharmova Limited | 14.45 Billion INR | 95.988% |
Laurus Labs Limited | 11.9 Billion INR | 95.131% |
Lupin Limited | 125.09 Billion INR | 99.536% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -257.452% |
Medico Remedies Limited | 59.67 Million INR | -871.742% |
Nectar Lifesciences Limited | 932.7 Million INR | 37.827% |
RPG Life Sciences Limited | 1.63 Billion INR | 64.544% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 77.296% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.624% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 58.662% |
Unichem Laboratories Limited | 6.72 Billion INR | 91.378% |
Vaishali Pharma Limited | 84.02 Million INR | -590.103% |
Venus Remedies Limited | 1.91 Billion INR | 69.739% |
Windlas Biotech Limited | 1 Billion INR | 42.386% |
ZIM Laboratories Limited | 1.01 Billion INR | 42.759% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 46.016% |
Orchid Pharma Limited | 800.77 Million INR | 27.584% |
Procter & Gamble Health Limited | 2.99 Billion INR | 80.641% |
Wanbury Limited | 978.96 Million INR | 40.765% |
Ipca Laboratories Limited | 18.98 Billion INR | 96.946% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 81.138% |
Brooks Laboratories Limited | 51.18 Million INR | -1033.034% |
Eris Lifesciences Limited | 4.94 Billion INR | 88.268% |
Sakar Healthcare Limited | 204.07 Million INR | -184.148% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.958% |
Divi's Laboratories Limited | 14.17 Billion INR | 95.908% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 76.556% |
Mankind Pharma Limited | 29.27 Billion INR | 98.019% |
Sequent Scientific Limited | 2.9 Billion INR | 80.016% |
Neuland Laboratories Limited | 2.92 Billion INR | 80.207% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 96.08% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.765% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.537% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 72.308% |
Wockhardt Limited | 8.48 Billion INR | 93.162% |
Bal Pharma Limited | 555.62 Million INR | -4.366% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.395% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 59.141% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -894.865% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 73.332% |
Shilpa Medicare Limited | 3.33 Billion INR | 82.608% |
Valiant Laboratories Limited | 138.02 Million INR | -320.12% |
Ajanta Pharma Limited | 30.46 Billion INR | 98.096% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -3979.976% |
Granules India Limited | 10.31 Billion INR | 94.377% |
Medicamen Biotech Limited | 335.16 Million INR | -73.014% |
Syncom Formulations (India) Limited | 345.63 Million INR | -67.775% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.089% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 97.293% |
NATCO Pharma Limited | 10.05 Billion INR | 94.235% |
Suven Life Sciences Limited | 109.75 Million INR | -428.371% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1156.363% |
Strides Pharma Science Limited | 9.16 Billion INR | 93.671% |
Indoco Remedies Limited | 12.06 Billion INR | 95.192% |
Alpa Laboratories Limited | 127.38 Million INR | -355.242% |
Lasa Supergenerics Limited | 291.17 Million INR | -99.155% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 81.153% |